Seattle, WA -- (SBWIRE) -- 11/14/2019 -- Flow cytometry is an instrument broadly used for cell counting, cell sorting, biomarker detection, and protein engineering. The process is carried out by suspending cells in a stream of fluid and passing them into an electronic detection apparatus. Flow cytometry process is broadly used in the diagnosis of various diseases such as blood cancers with several applications in basic research, clinical practice, and clinical trials. Moreover, flow cytometry also offer the study of the expression of cell surface and intracellular molecules and characterization of various cell types in a heterogeneous cell population. Furthermore, it also allows for simultaneous multi-parameter analysis of single cells. The market growth of this market primarily depends on the increasing introduction of advanced technologies, rising research activities in the life science field and increasing application of flow cytometry in the detection of HIV and cancers.
Recently this technology has undergone new developments with the availability of robust photodetectors and new laser emitters, lED lamps as emitter, and changes in analytical capacity. In addition to this, the introduction of advancement in flow cytometry for routine laboratory procedures, such as imaging, which acquires images of cells possible in real-time as they pass by the interrogation point are some of the major advancements in flow cytometry. This process is also used in cytology, hematology, immunology, and microbiology, among other research fields.
On the other hand, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth.
The global flow cytometry market was valued at US$ 3.2 Bn in 2016 and is expected to witness a robust CAGR of 10.2 % over the forecast period (2017-2025).
Download A Readymade Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-sample/1152
Rising clinical applications of flow cytometry are projected to favor the flow cytometry market
The increasing application of flow cytometry in the clinical laboratory for various research purposes such as immunophenotyping, cell sorting, cell cycle analysis, apoptosis, cell proliferation assays, and intracellular calcium flux is expected to favor the growth of flow cytometry market. Moreover, flow cytometry has a unique ability to determine large cell populations at the single-cell level is expected to raise the adoption of flow cytometry.
Furthermore, flow cytometry is also gaining traction in drug discovery and development, which helps to transform every stage of preclinical and clinical development, that guide new product evaluation, selection, and monitoring. Moreover, flow cytometry increases the probability of success in drug development and also offer for more informed decision making. The demand for flow cytometry is growing at all phases of development from early to late which is expected to favor the growth of flow cytometry use in industry for the drug development process.
Flow cytometry is also widely used in the testing of CD4 count for treating HIV patients with suitable antiretroviral drugs. The BD Biosciences provides CD4 testing facilities and products. BD Biosciences has 3 different systems, namely, BD FACSCount system, mostly used in emerging economies, owing to its ease of use; the BD FACSCalibur system is used in large-volume labs where over 1,000,000 tests are performed annually, and the BD FACSCanto II system, used for HIV monitoring and other applications. North America dominates the global flow cytometry market
North America held leding position in the global flow cytometry market, followed by Europe and this can be attributed to growing research and advancement in technology and rapid acceptance of the flow cytometry and growth of the life sciences sector in developed countries such as the U.S. Asia Pacific flow cytometry market is projected to show a high growth rate owing to the increasing prevalence of HIV. According to Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, around 49,00,000 HIV infected people aged 15 years and above were living in the Asia Pacific region, which in turn is expected to propel the market growth in the Asia Pacific region.
Some major players operating in the flow cytometry market are Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc. and Danaher Corporation.
Get Customized Report as per your Need: https://www.coherentmarketinsights.com/insight/request-customization/1152
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.